The Path from Anti Parkinson Drug Selegiline and Rasagiline to Multifunctional Neuroprotective Anti Alzheimer Drugs Ladostigil and M30

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|3|5|541-550

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.3, Iss.5, 2006-12, pp. : 541-550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Multifunctional Anti-Alzheimer Drugs with Various CNS Neurotransmitter Targets and Neuroprotective Moieties

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-12 ,pp. : 522-536

Bentham Science Publishers

Access to resources Recommend Favorite

Up-Regulation of Hypoxia-Inducible Factor (HIF)-1 and HIF-Target Genes in Cortical Neurons by the Novel Multifunctional Iron Chelator Anti-Alzheimer Drug, M30

By  

Current Alzheimer Research, Vol. 7, Iss. 4, 2010-06 ,pp. : 300-306

Bentham Science Publishers

Access to resources Recommend Favorite

Multifunctional neuroprotective–neurorescue drugs for Parkinson’s disease

By Van der Schyf Cornelis J   Geldenhuys Werner J   Youdim Moussa BH  

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 411-423

Future Medicine

Access to resources Recommend Favorite

From Anti-allergic to Anti-Alzheimer’s: Molecular Pharmacology of Dimebon™

By  

Current Alzheimer Research, Vol. 7, Iss. 2, 2010-03 ,pp. : 97-112

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a New Treatment for Alzheimer's Disease and Parkinson's Disease Using Anti-Aggregatory β-Synuclein-Derived Peptides

By Windisch M.   Hutter-Paier B.   Rockenstein E.   Hashimoto M.   Mallory M.   Masliah E.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 63-70

Humana Press, Inc

Access to resources Recommend Favorite